Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
K-163-SZ Phase 2 placebo-controlled study in schizophrenia with negative symptoms
jRCT2080223724Phase 2Completed
- Sponsor
- Kowa Company, Ltd.
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in schizophrenia comparing K-163 arm with Placebo arm (2 arms). Started Nov 2017; status: completed.
02
Drugs
pyridorin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on jRCT2080223724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223724.